Capilla
ry liquid ch
romatog
raphy/mic
roelect
rosp
ray-massspect
romet
ry (capilla
ry LC/
r.gif">ESI-MS) was used to quantifyDNA adducts of the hete
rocyclic a
romatic amine 2-amino-3-methylimidazo[4,5-
f]quinoline (IQ) in live
rs of maleFische
r-344
rats. Animals
received a single o
ral dose ofeithe
r 0.05, 0.50, 1.0, o
r 10 mg/kg IQ and we
resac
rificed 24 h following t
reatment. The majo
r lesionidentified at all doses was
N-(deoxyguanosine-8-yl)-2-amino-3-methylimidazo[4,5-
f]quinoline (dG-C8-IQ). Thecapilla
ry LC/
r.gif">ESI-MS method p
rovided the means fo
rquantifying 17.5 fmol of dG-C8-IQ (2.0 adducts in 10
8nucleosides) (S/N 10) in 300
r.gif">g of live
r DNA with anint
ra- and inte
rday p
recision of 3.5 and 6.6% (RSD),
respectively. dG-C8-IQ was quantified with a mean int
ra-and inte
rday accu
racy of 105 ± 26 and 106 ± 28 (SD)based on back-calculated adduct masses f
rom five standa
rd cu
rves analyzed ove
r a fou
r-week pe
riod. This is thefi
rst
repo
rt on development of a capilla
ry LC/
r.gif">ESI-MSmethod to quantify dG-C8-IQ adducts in live
r DNA of
ratsfollowing dosing with IQ at diffe
rent levels. Fu
rthe
rmo
re,the ability to accu
rately and p
recisely quantify dG-C8-IQ at a level of 2.0 adducts in 10
8 nucleosides in vivomakes this method well suited fo
r use in futu
re studies
relating ca
rcinogen exposu
re to
risk in humans.